Great Ormond Street Hospital to participate in the 3rd Kuwait Medica Conference and Exhibition

The conference, which aims to bring together the latest trends, products, services and ideas in healthcare, will take place from 16th - 18th April 2012 at The Marriott Courtyard, Kuwait. At the conference, members of the GOSH team will deliver detailed presentations about the hospital's work, and the programmes and treatments available to patients and their parents living in the region.

Dr. Phil Ancliff, consultant haematologist at GOSH and one of the key speakers at the conference, said: "There is a strong demand for specialist children's healthcare services in Kuwait. This exhibition provides an opportunity to share best practice in paediatric patient care with medical and healthcare professionals, to stay current with the latest developments and innovations within the industry, and to showcase the services provided by GOSH in Kuwait through our partnership with the Ministry of Health."

Dr. Ancliff will speak about the treatment of childhood leukaemia, other cancers and blood diseases. He will also touch on the partnership between GOSH and the Kuwait Ministry of Health and will conclude with the benefits of the programme and Minimal Residual Disease (MRD) as a leading edge technology to Kuwaiti patients.

At the conference, GOSH is keen to reach out to both investors and visitors who are keen to learn about the hospital's services. GOSH's team will deliver detailed presentations about "Treating childhood leukaemia, other cancers and blood disease: a partnership between Great Ormond Street Hospital and the Kuwait Ministry of Health."

In Kuwait GOSH has established a successful working partnership with NBK Hospital. Senior GOSH medical staff have been providing practical support and training to NBK nurses and doctors which has increased understanding of paediatric procedures, diagnosis and care in a clinical setting. GOSH also provides leading edge diagnostic capability to patients in Kuwait through its Minimal Residual Disease (MRD) testing for children with leukemia at NBK hospital.